Fig. 1From: Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settingsReceiver-operator characteristic curve for predicting pre-treatment HIV RNA <100,000 copies/mL among derivation patients with data on all included variables (n = 1757)Back to article page